RecruitingNCT06849635

Cera™ ASD Occluder Post-Market Clinical Follow-Up Study

Studying Interatrial communication

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
Enrollment: 139 enrolled
Eligibility: All sexes
Timeline: 2025 – 2026

Study locations (6)

G.V.M.Carint Hospital, Myszków, Poland
Centre for Invasive Cardiology, Electrotherapy and Angiology G.V.M.Carint-Oswiecim, Oświęcim, Poland
Subcarpathian Centre for Cardiovascular Intervention G.V.M.Carint -Sanok, Sanok, Poland
Polish-American Heart Clinics, Heart and Vascular Center in Tychy, American Heart of Poland Group, Tychy, Poland
Polish-American Heart Clinics 1st Department of Invasive Cardiology and Heart Failure in Ustroń, AHoP Group, Ustroń, Poland
Dr. Tytus Chałubiński County Hospital, Zakopane, Poland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06849635 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication →

← Back to all trials